Product Security
B. Braun ensures high security standards
B. Braun ensures high security standards throughout the product life cycle by using globally accepted standards. We have established processes to monitor the latest vulnerabilities, threats, or risks and will proactively implement measures as required. We have developed processes to reflect our corporate values and to uphold our responsibilities both legal and to good-faith security researchers that provide us with their expertise.
B. Braun Coordinated Vulnerability Disclosure
We welcome vulnerability reports from researchers, industry groups, CERTs, partners and any other source. We will give full credit on our website once the submission has been accepted and validated by our product security team.
Overview
B. Braun’s Vulnerability Disclosure Program initially covers medical devices, combination products and healthcare related software.
Use the form provided on our webpage or email data to productsecurity@bbraun.com including:
-Your reference/advisory number and sufficient contact information, such as your organization and contact name so that we can get in touch with you.
- A technical description of the concern or vulnerability.
- On which specific product you tested, including product name and version number.
- The technical infrastructure that was tested including operating system, version and network configuration details.
- For web-based services, the date and time of testing, URLs, the browser type, version as well as the input provided to the application.
-Any additional information, including details on the tools used to conduct the testing and any relevant test configurations. If you wrote specific proof-of-concept or exploit code, please provide a copy.
-If you have identified specific threats related to the vulnerability, assessed the risk, or have seen the vulnerability being exploited, please provide that information.
-If you communicate vulnerability information to vulnerability coordinators such as ICS-CERT, CERT/CC, NCSC or other parties, please include their tracking number if available.
- A timely response to your email (within two business days).
- After triage, we will send an expected timeline and commit to being as transparent as possible about the remediation timeline or challenges that may extend it.
- An open dialog to discuss issues.
- Notification when the vulnerability analysis has completed each stage of our review.
- Credit after the vulnerability has been validated and fixed.
- Public reporting of vulnerability in appropriate circumstances.
By submitting information, you agree that your submission will be governed by B. Braun’s Privacy Policy and Terms of Use.
We will not engage in legal action against individuals who submit reports through our vulnerability reporting process and enter into a legal agreement with us. We agree to work with individuals who:
-Engage in testing of systems/research without harming B. Braun or its customers and certainly patients.
-Adhere to the laws of their location and the location of B. Braun.
-Engage in vulnerability testing within the scope of our vulnerability disclosure program in accordance with the terms and conditions of any agreements entered into between B. Braun and individuals.
-Refrain from disclosing vulnerability details before any mutually agreed-upon timeframe expires.
-The discloser’s actions must not be disproportionate or in bad faith, such as:
- Using social engineering to gain access to the system.
- Building his or her own backdoor in an information system with the intention of then using it to demonstrate the vulnerability.
- Utilizing a vulnerability further than necessary to establish its existence.
- Copying, modifying or deleting data on the system or making changes to it.
- Repeatedly gaining access to the system or sharing access with others.
Questions or concerns about security?
Vulnerability Coordination Assistance
If you believe you have identified a potential security vulnerability in one of our products or services, please follow the coordinated disclosure process and fill out the form.
B. Braun security bulletins
B. Braun Product Security Bulletins contain product-specific security-related information. Our bulletins will list all known vulnerabilities for each product, the status and all recommended customer actions such as fixes or patches or other mitigation strategies. Revised bulletins are posted regularly with the latest available information.
Product security bulletins
Wednesday, March 15, 2023
3/2023 B. Braun Medical Inc. Statement regarding cybersecurity vulnerability with Space Battery Pack SP with Wi-Fi
Read More
Wednesday, December 7, 2022
12/2022 B. Braun Medical Inc. Statement regarding cybersecurity vulnerabilities identified by the Openssl Project
Read More
Tuesday, April 26, 2022
04/2022 B. Braun Medical Inc. Statement regarding cybersecurity vulnerabilities with Amnesia:33
Read More
Tuesday, April 26, 2022
04/2022 B. Braun Medical Inc. Statement regarding cybersecurity vulnerabilities concerning Name: Wreck
Read More
Friday, April 1, 2022
04/2022 B. Braun Medical Inc. Statement regarding cybersecurity vulnerabilities identified by Palo Alto Networks
Read More
Thursday, December 16, 2021
12/2021 B. Braun Medical Inc. Statement regarding cybersecurity vulnerability in the InterNiche Technologies TCP/IP Stack
Read More
Thursday, December 16, 2021
12/2021 B. Braun Medical Inc. Statement regarding cybersecurity vulnerability in the Apache Log4j 2 Java logging Library
Read More
Thursday, December 16, 2021
12/2021 B. Braun Medical Inc. Statement regarding cybersecurity vulnerability Nucleus TCP/IP Stack
Read More
Friday, October 8, 2021
10/2021 Update: B. Braun Statement on Cybersecurity Vulnerability with Ripple20 Communications Software
Read More
Friday, May 14, 2021
05/2021 Space® Infusion System Vulnerability Advisory
Read More
Wednesday, February 24, 2021
02/2021 OnlineSuite WiBu CodeMeter multiple vulnerabilities
Read More
Monday, October 26, 2020
10/2020 SpaceCom, Battery Pack SP with WiFi - multiple vulnerabilities
Read More
Monday, October 26, 2020
10/2020 Online Suite - multiple vulnerabilities
Read More
Monday, November 4, 2019
11/2019 B. Braun Medical Inc. Statement regarding cybersecurity vulnerability ICSMA-19-274-01 URGENT/11
Read More